Sridevi Devaraj, PhD, DABCC, FAACC, FRSC, CCRP
Medical Director of Clinical Chemistry and Point of Care Testing
Associate Director, Texas Children's Microbiome Center
Director of Laboratories, The Center for Children and Women
Program Director, Ching-Nan Ou Clinical Chemistry Fellowship, Baylor College of Medicine
Professor of Pathology & Immunology, Baylor College of Medicine
Languages: English
Departments:
Get to know Sridevi Devaraj, PhD, DABCC, FAACC, FRSC, CCRP
Personal Statement
Dr. Devaraj’s major research interests are atherosclerosis, inflammation, oxidative stress, antioxidants and diabetes and nutritional modulation of risk factors for heart disease. She is a Board certified clinical chemist. Her focus has been on investigating molecular and biochemical pathways contributing to inflammation, both at the systemic and cellular level. She has also made seminal observations with regards to cellular inflammation and toll like receptor pathways in diabetes. Her interest in nutrition has resulted in several publications on the nutritional modulation of oxidative stress, inflammation, diabetes and atherosclerosis. She has also been involved in clinical and translational research, especially as it relates to biomarkers and metabolic processes.
Education
,
,
Organizations
,
,
,
* Texas Children’s Hospital physicians’ licenses and credentials are reviewed prior to practicing at any of our facilities. Sections titled From the Doctor, Professional Organizations and Publications were provided by the physician’s office and were not verified by Texas Children’s Hospital.
Jiang JX, Chen X, Serizawa N, Szyndralewicz C, Page P, Schröder K, Brandes RP, Devaraj S, Török NJ. Liver fibrosis and hepatocyte apoptosis are attenuated by GKT137831 a novel NOX4/NOX1 inhibitor in vivo. Free Radical Biology & Medicine 2012 May 19.